Sweden has Europe’s most effective system for the substitution of pharmaceuticals

The assignment of the Dental and Pharmaceutical Benefits Agency (TLV) includes monitoring and analysing the development of pharmaceutical prices internationally. The purpose of this report is to compare the development of pharmaceutical prices in Sweden to prices in 19 other European countries. The comparison includes pharmaceuticals with and without generic competition. The report has been published annually since 2014.